Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.